Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...
Burlington Free Press on MSN
UVM joins major study on drug use and treatment barriers across New England
The initiative, funded by a $12 million grant from the National Institute on Drug Abuse, will evaluate how people with ...
Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...
Women are disproportionately affected by HIV, making up nearly half of new infections globally and in India. Stigma, gender ...
Last year, 444 people in the Netherlands were diagnosed with HIV, the virus that can cause AIDS. Almost 20 years ago, there ...
The United States has begun distributing a groundbreaking HIV-prevention treatment to two African nations, marking a ...
Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...
To mark World AIDS Day, the Institute for Contemporary Arts will screen our film tackling the collapse of USAID funding ...
The US delivers Lenacapavir HIV treatment to Eswatini and Zambia, expanding prevention efforts despite prior aid cuts under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results